Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tachycardia, Ventricular | 14 | 2023 | 115 | 3.370 |
Why?
|
| Catheter Ablation | 16 | 2023 | 233 | 2.220 |
Why?
|
| Heart Rate | 10 | 2023 | 492 | 1.620 |
Why?
|
| Atrial Fibrillation | 9 | 2021 | 288 | 1.560 |
Why?
|
| Body Surface Potential Mapping | 5 | 2021 | 22 | 1.430 |
Why?
|
| Pericardium | 3 | 2021 | 65 | 1.410 |
Why?
|
| Heart Conduction System | 6 | 2021 | 108 | 1.330 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 5 | 2021 | 39 | 1.260 |
Why?
|
| Electrocardiography | 8 | 2020 | 478 | 1.240 |
Why?
|
| Arrhythmias, Cardiac | 5 | 2023 | 187 | 0.920 |
Why?
|
| Pacemaker, Artificial | 4 | 2021 | 87 | 0.900 |
Why?
|
| Endocardium | 2 | 2021 | 76 | 0.870 |
Why?
|
| Heart Atria | 3 | 2021 | 250 | 0.870 |
Why?
|
| Atrial Function, Left | 1 | 2021 | 46 | 0.810 |
Why?
|
| Heart Ventricles | 5 | 2020 | 760 | 0.800 |
Why?
|
| Defibrillators, Implantable | 4 | 2022 | 129 | 0.710 |
Why?
|
| Bundle of His | 4 | 2019 | 42 | 0.660 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 240 | 0.590 |
Why?
|
| Atrial Flutter | 4 | 2020 | 33 | 0.500 |
Why?
|
| Aged | 24 | 2022 | 18402 | 0.420 |
Why?
|
| Cardiac Resynchronization Therapy | 3 | 2022 | 68 | 0.400 |
Why?
|
| Robotic Surgical Procedures | 1 | 2016 | 267 | 0.400 |
Why?
|
| Bundle-Branch Block | 3 | 2022 | 48 | 0.390 |
Why?
|
| Epicardial Mapping | 2 | 2021 | 10 | 0.380 |
Why?
|
| Male | 31 | 2022 | 40956 | 0.370 |
Why?
|
| Cardiac Pacing, Artificial | 3 | 2018 | 87 | 0.350 |
Why?
|
| Device Removal | 2 | 2021 | 161 | 0.350 |
Why?
|
| Middle Aged | 24 | 2022 | 25017 | 0.300 |
Why?
|
| Humans | 36 | 2023 | 86601 | 0.270 |
Why?
|
| Predictive Value of Tests | 5 | 2021 | 1673 | 0.260 |
Why?
|
| Cicatrix | 2 | 2023 | 63 | 0.240 |
Why?
|
| Female | 26 | 2022 | 44507 | 0.240 |
Why?
|
| Action Potentials | 3 | 2021 | 573 | 0.230 |
Why?
|
| Nadolol | 2 | 2020 | 4 | 0.220 |
Why?
|
| Flecainide | 2 | 2020 | 7 | 0.220 |
Why?
|
| Echocardiography | 2 | 2019 | 911 | 0.220 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 2 | 2019 | 19 | 0.210 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 2019 | 58 | 0.210 |
Why?
|
| Ventricular Premature Complexes | 1 | 2021 | 7 | 0.210 |
Why?
|
| Prospective Studies | 9 | 2023 | 4210 | 0.210 |
Why?
|
| Tachycardia, Atrioventricular Nodal Reentry | 2 | 2018 | 20 | 0.200 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 1 | 2021 | 10 | 0.200 |
Why?
|
| Prosthesis-Related Infections | 1 | 2021 | 58 | 0.190 |
Why?
|
| Heart Failure | 2 | 2022 | 1203 | 0.190 |
Why?
|
| Vena Cava, Superior | 1 | 2020 | 59 | 0.180 |
Why?
|
| Cardiovascular Agents | 1 | 2020 | 56 | 0.180 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 3636 | 0.180 |
Why?
|
| Ultrasonography, Interventional | 1 | 2020 | 121 | 0.180 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2019 | 23 | 0.170 |
Why?
|
| Purkinje Fibers | 1 | 2019 | 27 | 0.170 |
Why?
|
| Heart Septum | 1 | 2019 | 45 | 0.170 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2019 | 25 | 0.170 |
Why?
|
| Aged, 80 and over | 6 | 2022 | 6501 | 0.170 |
Why?
|
| Sick Sinus Syndrome | 1 | 2018 | 9 | 0.170 |
Why?
|
| Precipitating Factors | 1 | 2018 | 5 | 0.170 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2019 | 73 | 0.170 |
Why?
|
| Feasibility Studies | 5 | 2021 | 751 | 0.170 |
Why?
|
| Baseball | 1 | 2018 | 17 | 0.160 |
Why?
|
| Atrioventricular Block | 1 | 2018 | 23 | 0.160 |
Why?
|
| Pulmonary Veins | 1 | 2019 | 72 | 0.160 |
Why?
|
| Myocardial Ischemia | 1 | 2019 | 162 | 0.160 |
Why?
|
| Gene Deletion | 1 | 2019 | 329 | 0.160 |
Why?
|
| Atrioventricular Node | 1 | 2017 | 33 | 0.160 |
Why?
|
| Exons | 1 | 2019 | 450 | 0.150 |
Why?
|
| Retrospective Studies | 9 | 2023 | 8475 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 746 | 0.140 |
Why?
|
| Risk Assessment | 4 | 2020 | 2261 | 0.130 |
Why?
|
| Hemorrhage | 1 | 2017 | 268 | 0.130 |
Why?
|
| Stress, Psychological | 1 | 2018 | 313 | 0.130 |
Why?
|
| Coronary Angiography | 1 | 2016 | 232 | 0.130 |
Why?
|
| Anticoagulants | 1 | 2017 | 408 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2015 | 161 | 0.120 |
Why?
|
| Hospitalization | 1 | 2018 | 848 | 0.110 |
Why?
|
| Hernia, Ventral | 1 | 2012 | 24 | 0.110 |
Why?
|
| Risk Factors | 7 | 2020 | 5416 | 0.110 |
Why?
|
| Treatment Outcome | 7 | 2022 | 7988 | 0.110 |
Why?
|
| Oseltamivir | 1 | 2011 | 20 | 0.100 |
Why?
|
| Inappropriate Prescribing | 1 | 2011 | 18 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 1204 | 0.100 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 102 | 0.100 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2011 | 344 | 0.090 |
Why?
|
| Thrombosis | 1 | 2011 | 296 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2011 | 329 | 0.080 |
Why?
|
| Incidence | 3 | 2018 | 1576 | 0.080 |
Why?
|
| Antiviral Agents | 1 | 2011 | 510 | 0.080 |
Why?
|
| Recurrence | 2 | 2019 | 1139 | 0.070 |
Why?
|
| Laparoscopy | 1 | 2012 | 754 | 0.070 |
Why?
|
| Pandemics | 1 | 2011 | 740 | 0.070 |
Why?
|
| Prevalence | 2 | 2018 | 1239 | 0.060 |
Why?
|
| Atropine | 1 | 2023 | 59 | 0.060 |
Why?
|
| Heart Block | 1 | 2023 | 32 | 0.060 |
Why?
|
| Adolescent | 4 | 2020 | 8979 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2023 | 165 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2705 | 0.050 |
Why?
|
| Adult | 6 | 2021 | 25640 | 0.050 |
Why?
|
| Ventricular Fibrillation | 1 | 2021 | 65 | 0.050 |
Why?
|
| Prognosis | 2 | 2019 | 3674 | 0.050 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 29 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2023 | 710 | 0.050 |
Why?
|
| Sympathectomy | 1 | 2020 | 42 | 0.040 |
Why?
|
| Cardiac Catheters | 1 | 2019 | 9 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2020 | 278 | 0.040 |
Why?
|
| Indiana | 1 | 2019 | 12 | 0.040 |
Why?
|
| Exercise Test | 1 | 2020 | 164 | 0.040 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2019 | 27 | 0.040 |
Why?
|
| Patient Selection | 1 | 2022 | 685 | 0.040 |
Why?
|
| Malaysia | 1 | 2017 | 12 | 0.040 |
Why?
|
| Myocardial Contraction | 1 | 2019 | 244 | 0.040 |
Why?
|
| United States | 2 | 2022 | 6665 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 1685 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2011 | 1990 | 0.040 |
Why?
|
| Heart | 1 | 2020 | 539 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2019 | 456 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2017 | 684 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 579 | 0.030 |
Why?
|
| Stroke | 2 | 2017 | 965 | 0.030 |
Why?
|
| Young Adult | 2 | 2021 | 5974 | 0.030 |
Why?
|
| Ofloxacin | 1 | 1995 | 5 | 0.030 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2017 | 229 | 0.030 |
Why?
|
| Neutropenia | 1 | 1995 | 215 | 0.030 |
Why?
|
| Fever | 1 | 1995 | 125 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 1054 | 0.030 |
Why?
|
| Logistic Models | 1 | 2017 | 1185 | 0.030 |
Why?
|
| Phenotype | 1 | 2020 | 2377 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 1995 | 181 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 1801 | 0.030 |
Why?
|
| United Arab Emirates | 1 | 2012 | 1 | 0.030 |
Why?
|
| Seroma | 1 | 2012 | 6 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2012 | 173 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 2767 | 0.030 |
Why?
|
| Hematoma | 1 | 2012 | 104 | 0.030 |
Why?
|
| Herniorrhaphy | 1 | 2012 | 79 | 0.030 |
Why?
|
| Surgical Mesh | 1 | 2012 | 116 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 307 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 5209 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2011 | 678 | 0.020 |
Why?
|
| Length of Stay | 1 | 2012 | 700 | 0.020 |
Why?
|
| Chicago | 1 | 2011 | 1379 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2012 | 2207 | 0.010 |
Why?
|
| Child | 1 | 2011 | 6926 | 0.010 |
Why?
|
| Neoplasms | 1 | 1995 | 2897 | 0.010 |
Why?
|
| Fever of Unknown Origin | 1 | 1995 | 5 | 0.010 |
Why?
|
| Survival Analysis | 1 | 1995 | 1538 | 0.010 |
Why?
|